- Endocrine complications of modern cancer therapy2016 | Faculty of Medicine in Hradec Králové
- Immune Checkpoint Inhibitor Myocarditis: Current Views on Diagnosis and Treatment2022 | First Faculty of Medicine
- COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma2022 | Third Faculty of Medicine
- International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System2023 | Faculty of Medicine in Hradec Králové
- Immune-related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors2020 | Faculty of Medicine in Pilsen
- Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors' treatment: Spectrum of imaging appearances2018 | Second Faculty of Medicine, Third Faculty of Medicine
- The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma2023 | Faculty of Medicine in Pilsen
- Identifying predictors of response to unresectable hepatocellular carcinoma treatment with checkpoint inhibitors remains a challenge for the future2021 | Publication without faculty affiliation
- Treatment of metastatic renal cell carcinoma in higher lines - patients after progression on TKI and immune checkpoint inhibitor2022 | First Faculty of Medicine
- Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care2021 | Faculty of Medicine in Pilsen
- Autoimmune diabetes due to immunotherapy of malignant melanoma2020 | Second Faculty of Medicine
- Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study2022 | First Faculty of Medicine
- Current Immunotherapy Approaches in Non-Hodgkin Lymphomas2020 | First Faculty of Medicine
- A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade2023 | First Faculty of Medicine, Second Faculty of Medicine
- Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe An initiative of the Central European Cooperative Oncology Group (CECOG)2022 | Publication without faculty affiliation
- Differential diagnosis of pituitary enlargement2022 | First Faculty of Medicine
- Plasma PD-L1 as a biomarker in the clinical management of glioblastoma multiforme-a retrospective cohort study2023 | Publication without faculty affiliation
- Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme2017 | Faculty of Medicine in Pilsen
- LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells2021 | Second Faculty of Medicine
- Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma2019 | Faculty of Medicine in Pilsen
- Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors2022 | Second Faculty of Medicine, Central Library of Charles University
- Translation in solid cancer: are size-based response criteria an anachronism?2015 | Faculty of Science
- Biological Therapy of Hematologic Malignancies: Toward a Chemotherapy-free Era2019 | First Faculty of Medicine
- Immunotherapy in the first line treatment of non-small cell lung cancer2020 | Faculty of Medicine in Pilsen
- Fecal microbiota transplantation - new possibility to influence the results of therapy of cancer patients2022 | First Faculty of Medicine, Second Faculty of Medicine
- Hodgkin's lymphoma in the elderly patients2018 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Immunology and tumor immunotherapy: contemporary knowledge quickly and easily2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Recent advances in tartgeted therapy of renal cell carcinoma2016 | First Faculty of Medicine
- Nivolumab induced encephalopathy in a man with metastatic renal celll cancer: a case report2018 | Faculty of Medicine in Hradec Králové